TR201003579A2 - Alt ve üst deri hastaliklarının topikal ve enjekte edilebilir bir yara iyileştirme ajan ile tedavisi. - Google Patents

Alt ve üst deri hastaliklarının topikal ve enjekte edilebilir bir yara iyileştirme ajan ile tedavisi.

Info

Publication number
TR201003579A2
TR201003579A2 TR2010/03579A TR201003579A TR201003579A2 TR 201003579 A2 TR201003579 A2 TR 201003579A2 TR 2010/03579 A TR2010/03579 A TR 2010/03579A TR 201003579 A TR201003579 A TR 201003579A TR 201003579 A2 TR201003579 A2 TR 201003579A2
Authority
TR
Turkey
Prior art keywords
skin diseases
topical
wound healing
healing agent
oil
Prior art date
Application number
TR2010/03579A
Other languages
English (en)
Inventor
Di̇zman Mümi̇n
Original Assignee
Di̇zman Mümi̇n
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Di̇zman Mümi̇n filed Critical Di̇zman Mümi̇n
Priority to TR2010/03579A priority Critical patent/TR201003579A2/tr
Publication of TR201003579A2 publication Critical patent/TR201003579A2/tr
Priority to PCT/TR2011/000100 priority patent/WO2011139246A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Hümik asitler, sodyum humat veya potasyum humat, fenolik polimeri olan polifenoller, fülvik asitler ve bitkisel/madensel kaynaklı ekstrakte edilmiş organik maddeler ile polivinilpirolidon karışımı pilonidal sinüs ve benzeri deri hastalıklarını hem topikal hem de enjekte edilebilir formda tedavi eden bir beşeri ilaç olarak kullanılmıştır . Tercih edilen hümik asit ve tuzları afşin elbistan gyttja’sından elde edilmiştir . Sonuçta oluşan hümik asit ile polivinilpirolidon :1 oranında, çörek otu yağı, kantaron yağı ve havuç yağı gibi bitkisel yağlarla 90 d/d motoru olan bir mikserde ph 6-12 aralığında, 20-90 derece santigratta, 2 24 saatte karıştırılarak pilonidal sinüs ve benzeri deri hastalıklarında kullanılmak üzere bir yara iyileştirme ajanı haline getirilmiştir .
TR2010/03579A 2010-05-06 2010-05-06 Alt ve üst deri hastaliklarının topikal ve enjekte edilebilir bir yara iyileştirme ajan ile tedavisi. TR201003579A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2010/03579A TR201003579A2 (tr) 2010-05-06 2010-05-06 Alt ve üst deri hastaliklarının topikal ve enjekte edilebilir bir yara iyileştirme ajan ile tedavisi.
PCT/TR2011/000100 WO2011139246A1 (en) 2010-05-06 2011-05-06 Topical or injectable composition comprising humic acid salts and polyvinylpyrrolidone for the treatment of skin diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/03579A TR201003579A2 (tr) 2010-05-06 2010-05-06 Alt ve üst deri hastaliklarının topikal ve enjekte edilebilir bir yara iyileştirme ajan ile tedavisi.

Publications (1)

Publication Number Publication Date
TR201003579A2 true TR201003579A2 (tr) 2010-07-21

Family

ID=42795460

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/03579A TR201003579A2 (tr) 2010-05-06 2010-05-06 Alt ve üst deri hastaliklarının topikal ve enjekte edilebilir bir yara iyileştirme ajan ile tedavisi.

Country Status (2)

Country Link
TR (1) TR201003579A2 (tr)
WO (1) WO2011139246A1 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10183047B2 (en) 2014-05-21 2019-01-22 Natreon, Inc. Chromium-containing compositions in combination with Phyllanthus emblica and shilajit having synergistic effects for improving endothelial function and cardiovascular health
CA3173584A1 (en) 2014-10-02 2016-04-07 Natreon, Inc. Promoting muscle building and repair and treating disorders related to collagen and pertinent proteins by using shilajit
US9820953B2 (en) * 2016-02-26 2017-11-21 Omni Bioceutical Innovations, Inc. Compositions of bioactive fulvate fractions and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3615780A (en) 1969-05-28 1971-10-26 Itt Rayonier Inc Silicate-catalyzed chemical grouting compositions
DE3707909A1 (de) 1987-03-12 1988-09-22 Ruetgerswerke Ag Niedermolekulare alkalihuminate, verfahren zu ihrer herstellung und verwendung
DE4134384A1 (de) * 1991-10-17 1993-04-22 Ruetgerswerke Ag Modifizierte huminate, verfahren zu ihrer herstellung und verwendung
ES2173925T3 (es) 1993-09-24 2002-11-01 Maurizio Zanetti Tratamiento de una infeccion vih con acido humico.
US5626881A (en) 1995-05-16 1997-05-06 Menefee Mining Corporation Humate dietary supplement
US6534049B2 (en) 1997-02-10 2003-03-18 Laub Biochemicals Corp. Synthetic soil-extract materials and medicaments for human immunodeficiency viruses based thereon
US6576229B2 (en) 1997-02-10 2003-06-10 Laub Biochemicals Corp. Synthetic soil-extract materials and medicaments for influenza viruses based thereon
US6524567B2 (en) 1997-02-10 2003-02-25 Laub Biochemicals Corp. Synthetic soil-extract materials and medicaments for hemorrhagic fever viruses based thereon
US5945446A (en) 1997-02-10 1999-08-31 Laubc Biochemicals, Corporation Process for preparing synthetic soil-extract materials and medicaments based thereon
CN1156274C (zh) * 2002-03-28 2004-07-07 中国科学院新疆理化技术研究所 一种含共轭亚油酸锌盐和腐殖酸钠的药用软膏
US7067155B2 (en) 2003-01-03 2006-06-27 Tbni, Inc. Anti-inflammatory humate compositions and methods of use thereof
JP5383963B2 (ja) * 2005-03-29 2014-01-08 エンザイム株式会社 腐植、腐植抽出液および保湿液、ならびにそれらの製造方法および使用
TR200700973A2 (tr) * 2007-02-20 2007-10-22 Di̇zman Mümi̇n Pilonidal sinüsün polifenoller ile tedavisi.
WO2009158667A2 (en) * 2008-06-27 2009-12-30 Comgenrx, Inc. Povidone compositions for wound healing

Also Published As

Publication number Publication date
WO2011139246A4 (en) 2013-04-04
WO2011139246A1 (en) 2011-11-10
WO2011139246A8 (en) 2012-05-31
WO2011139246A9 (en) 2013-02-07

Similar Documents

Publication Publication Date Title
EA200970931A1 (ru) Аналоги гетероариламидов
NI201100082A (es) Compuestos de isoindolina para uso en el tratamiento de cáncer.
EA200970516A1 (ru) Гетероариламидные производные
BRPI0919447B8 (pt) compostos derivados de ácido 1-amino-2- ciclobutiletilborônico, composição farmacêutica e uso dos mesmos para tratar câncer
ATE395905T1 (de) Pharmazeutische zusammensetzungen in form fester dispersionen zur behandlung von krebs
MX2019000547A (es) Formulaciones de adamts13 liquidas y liofilizadas, estabilizadas.
BR112012005029A2 (pt) ácidos sulfo-peroxicarboxílicos, seu preparo e métodos de uso como agentes alvejantes e antimicrobianos.
BR112012011430A8 (pt) Compostos moduladores de receptor de esfingosina 1 fosfato e composições farmacêuticas
BR112012033091A2 (pt) método de cimentação, e, composição de cimento
BRPI0704008A2 (pt) uso de glicerina, método para tratamento de culturas, composição de mistura em tanque e um método para a preparação de uma composição de mistura em tanque
TR201909466T4 (tr) Düşük serbest stearik asit içeren veya tespit edilebilen hiç serbest stearik asit içermeyen, stearik asitle işlenmiş kalsiyum karbonat bileşimleri ve ilgili yöntemler.
BR112013000639A2 (pt) método de cimentação em uma formação subterrânea, e, composição de tratamento de poço
WO2013112651A3 (en) Proteasome activity modulating compounds
TR201003579A2 (tr) Alt ve üst deri hastaliklarının topikal ve enjekte edilebilir bir yara iyileştirme ajan ile tedavisi.
ES2519618T3 (es) Procedimiento de despolimerización de la celulosa, catalizada por ácido
TR201001251A2 (tr) Saç bakımı ve dökülmesi, kellik, yanık tedavisi ve masajda kullanılan bitkisel yağ.
FI20085608A7 (fi) Lietelannan fosforipitoisuuden alentaminen
MX2011007885A (es) Formulaciones de emulsion de narcoticos para tratamiento de dolor por cancer.
BR112015014141A2 (pt) método de hidrólise de biomassa vegetal
NZ602703A (en) Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport
RU2010133199A (ru) Способ получения биоудобрения
CU22693A1 (es) Composición para el tratamiento de la psoriasis y método para su obtención
BR112022001319A2 (pt) Composição de extrato botânico
TR201101483A2 (tr) Hümik asit ile esansiyel/herbal yağlar karışımı şampuan.
MX352422B (es) Composiciones de cemento bioactivas de autoendurecimiento con quitina parcialmente desacetilada como sustitutos de injertos de hueso.